Adjuvant Therapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Adjuvant Therapy
Jun 25, 2024, 14:07 |
Insight
Piotr Wysocki: Minimally invasive surgery is out of the question in cervical cancer
Piotr Wysocki recently posted on LinkedIn: "Pedro Ramirez et al. published the results of the phase…
Jun 21, 2024, 11:04 |
Insight
Niklas Klümper: CtDNA will play an important role for tailoring treatment of MIBC
Niklas Klümper, Resident in Urology and Researcher at the Institute for Experimental Oncology at the…
Jun 4, 2024, 13:13 |
Insight
Tanja Obradovic: NADINA trial making history at ASCO2024 plenary session
Tanja Obradovic shared on LinkedIn: . "NADINA trial making history today at ASCO2024 plenary session.…
May 20, 2024, 14:44 |
Blog
Syed A. Ahmad: Our review on neoadjuvant and adjuvant therapy for resectable pancreas cancer
Syed A. Ahmad, Director at University of Cincinnati Cancer Center & Chief of Surgical Oncology…
Apr 16, 2024, 11:25 |
Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 12:45 |
Insight
Important IMvoke010 trial could shape future research in immunotherapy in locally advanced head and neck cancer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X/Twitter: "Important IMvoke010 trial could shape future research in immunotherapy…
Apr 7, 2024, 03:41 |
Insight
Sarah Sammons: How do we tailor adjuvant therapy without axillary dissection?
Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center, recently shared a post by Massimo…
Dec 12, 2023, 17:44 |
Insight
Piotr Wysocki: SABCS2023 - Adjuvant chemoimmunotherapy does not benefit TNBC patients
Piotr Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared on LinkedIn: "SABCS2023…
Sep 27, 2023, 18:17 |
Insight
Yüksel ÜRÜN: Our paper titled "Adjuvant Therapy for Renal Cell Carcinoma: A Systematic Review of Current Landscape and Future Directions" is now online.
Quoting Yüksel ÜRÜN, Professor at the Ankara University School of Medicine in Turkey, on X/Twitter:…
All:
9
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube